Ingevity Corporation (NYSE: NGVT) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connecti
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ingevity upgraded to Outperform at BMO Capital, which believes the company's exit from the CTO business and strategic review of its PC business could unlock value.
Ingevity Corporation (NYSE: NGVT) today issued the following letter to stockholders in response to the presentation issued by Vision One Management Partners (â
Ingevity Corporation (NYSE: NGVT) today reported its financial results for the fourth quarter and full year 2024.
Fourth quarter (Q4) net sales of $298.8 mill
Ingevity (NGVT) projects net sales and adjusted EBITDA for fiscal year 2024, exceeds guidance, explores strategic alternatives for Performance Chemicals.